Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU-PLGA-βTCP concentric system in a critical size defect in rats

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 5, 2013, Pages 873-884

  Rodriguez Evora M ^a   Delgado, A ^a,c   Reyes, R ^a   Hernandez Daranas A ^a   Soriano, I ^a   San Roman J ^b   Evora C ^a,c  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b CSIC   (Spain)

^c Facultad de Farmacia   (Spain)

Author keywords

BMP 2; Bone regeneration; In vivo degradation; SPU PLGA TCP system; Sustained delivery

Indexed keywords

CALCIUM PHOSPHATE; MICROSPHERE; POLYGLACTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE REGENERATION; CALVARIA; CONTROLLED STUDY; DEGRADATION KINETICS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84885068055     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.06.008     Document Type: Article

References (32)

1. Adhikari, R., Gunatillake, P.A., Griffiths, I., et al., 2008. Biodegradable injectable polyurethanes: synthesis and evaluation for orthopaedic applications. Biomaterials 29, 3762-3770.
2. Boerckel, J.D., Kolambar, Y.M., Dupont, K.M., et al., 2011. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32, 5241-5251.
3. Bohner, M., Baumgart, F., 2004. Theoretical model to determine the effects of geometrical factors on the resorption of calcium phosphate bone substitutes. Biomaterials 25, 3569-3582. (Pubitemid 38331991)
4. Brown, K.V., Li, B., Guda, T., et al., 2011. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng. Part A 17, 1735-1745.
5. De la Riva, B., Nowak, C., Sánchez, E., et al., 2009. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. Eur. J. Pharm. Biopharm. 73, 50-58.
6. De la Riva, B., Sánchez, E., Hernández, A., et al., 2010. Local controled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J. Control. Release 143, 45-52.
7. Delgado, J.J., Évora, C., Sánchez, E., et al., 2006. Validation of a method for noninvasive in vivo measurement of growth factor release from a local delivery system in bone. J. Control. Release 114, 223-229. (Pubitemid 44308501)
8. Dimitriou, R., Tsiridis, E., Giannoudis, P.V., 2005. Current concepts of molecular aspects of bone healing. Injury 36, 1392-1404. (Pubitemid 41618169)
9. Dorozhkin, S.V., 2011. Biocomposites and hybrid biomaterials based on calcium orthophosphates. Biomatter 1, 3-56.
10. Giannoudis, P.V., Dinopoulos, H., Tsiridis, E., 2005. Bone substitutes: an update. Injury 36, S20-S27.
11. Gogolewski, S., Gorna, K., 2007. Biodegradable polyurethane cancellous bone graft substitutes in the treatment of iliac crest defects. J. Biomed. Mater. Res. A 80, 94-101. (Pubitemid 44913337)
12. Hafeman, A.E., Zienkiewicz, K.J., Zachman, A.L., et al., 2011. Characterization of the degradation mechanisms of lysine-derived aliphatic poly(ester urethane) scaffolds. Biomaterials 32, 419-429.
13. Hernández, A., Sánchez, E., Soriano, I., et al., 2012a. Material-related effects of BMP-2 delivery systems on bone regeneration. Acta Biomater. 8, 781-791.
14. Hernández, A., Reyes, R., Sánchez, E., et al., 2012b. In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system. J. Biomed. Mater. Res. A 100, 2382-2391.
15. Huang, Z., Ren, P.-G., Ma, T., et al., 2010. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 51, 305-310.
16. Jeon, O., Song, S.J., Yang, H.S., et al., 2008. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem. Biophys. Res. Commun. 369, 774-780.
17. Kanczler, J.M., Ginty, P.J., White, L., et al., 2010. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31, 1242-1250.
18. Karageorgiou, V., Kaplan, D., 2005. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26, 5474-5491. (Pubitemid 40592136)
19. Kasten, P., Beyen, I., Niemeyer, P., et al., 2008. Porosity and pore size of betatricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study. Acta Biomater. 4, 1904-1915.
20. Li, B., Yoshii, T., Hafeman, A.E., et al., 2009a. The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. Biomaterials 30, 6768-6779.
21. Li, B., Davidson, J.M., Guelcher, S.A., et al., 2009b. The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. Biomaterials 30, 3486-3494.
22. Mastrogiacomo, M., Muraglia, A., Komlev, V., et al., 2005. Tissue engineering of bone: search for a better scaffold. Orthod. Craniofac. Res. 8, 277-284.
23. Seebach, C., Henrich, D., Kähling, C., et al., 2010. Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng. Part A 16, 1961-1970.
24. Sohier, J., Daculsi, G., Sourice, S., et al., 2010. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J. Biomed. Mater. Res. A 92, 1105-1114.
25. Tadokoro, M., Matsushima, A., Kotobuki, N., et al., 2012. Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells. J. Tissue Eng. Regen. Med. 6, 253-260.
26. Takahashi, Y., Yamamoto, M., Tabata, Y., 2005. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Biomaterials 26, 4856-4865. (Pubitemid 40343033)
27. Tazaki, J., Murata, M., Akazawa, T., et al., 2009. BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. Biomed. Mater. Eng. 19, 141-146.
28. Vo, T.N., Kasper, F.K., Mikos, A.G., 2012. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv. Drug Deliv. Rev. 64, 1292-1309.
29. von Doernberg, M.C., von Rechenberg, B., Bohner, M., et al., 2006. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials 27, 5186-5198. (Pubitemid 44096957)
30. Woodard, J.R., Hilldore, A.J., Lan, S.K., et al., 2007. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 28, 45-54. (Pubitemid 44427902)
31. Yoshii, T., Dumas, J.E., Okawa, A., et al., 2012. Synthesis, characterization of calcium phosphates/polyurethane composites for weight-bearing implants. J. Biomed. Mater. Res. B Appl. Biomater. 100, 32-40.
32. Yoshikawa, H., Myoui, A., 2005. Bone tissue engineering with porous hydroxyapatite ceramics. J. Artif. Organs 8, 131-136. (Pubitemid 41464669)